General News

General News | Jul. 28, 2015

Statement on the Results of Epratuzumab Study for the Treatment of Lupus

Results from a study of epratuzumab were released today. It did not meet its primary endpoint of clinically reducing the severity of lupus in people with mild to moderate disease. The following is a statement from Sandra C. Raymond, President and CEO

General News | Jul. 15, 2015

Lupus Foundation of America’s Collaboration in PARTNERS Seeks to Improve Pediatric Research and Care

Learn more about PARTNERS (Patients, Advocates and Rheumatology Teams Network for Research and Service), a new initiative.

General News | Jun. 17, 2015

Lupus Foundation of America Hosts Capitol Conversation on 21st Century Cures Moderated by Chuck Todd

National Advocacy Awards Dinner recognizes leaders from Congress, federal agencies, industry and the research community.

General News | Jun. 10, 2015

Activists Urge Congress To Expand Critical Funding for Lupus Research

Lupus Foundation of America Hosts Awards Dinner & 21st Century Cures Discussion

General News | Mar. 25, 2015

People With Lupus Must Have Access to Prescription Drugs

People with lupus need and deserve a full arsenal of treatments. With many new and innovative drugs for lupus in the drug pipeline, these highly anticipated treatments will mean nothing if people with lupus cannot afford them.

General News | Jan. 15, 2015

Lupus Organizations Collaborate to Further Advance Lupus Research

The request for nominations for the Lupus Insight Prize will open January 15, 2015 and will be awarded at the Federation of Clinical Immunology Societies (FOCIS) annual meeting in San Diego this June.

General News | Nov. 15, 2014

Lupus Research Studies Widen Understanding

Foundation-funded research studies highlighted at premier rheumatology meeting in Boston.

General News | Sep. 30, 2014

Foundation Announces Pediatric Lupus Research Grantee & LIFELINE Grant Program™ Recipients

The Lupus Foundation of America announced four grants that will allow lupus investigators to continue critical lupus research. Another grant will be used to develop a groundbreaking diagnostic tool for children with lupus-related kidney inflammation, or lupus nephritis.